Pulmonary adenocarcinoma of low malignant potential defines indolent NSCLC associated with overdiagnosis in the national lung screening trial.
Burks, Eric J, Travis B Sullivan, and Kimberly M Rieger-Christ. 2025. “Pulmonary Adenocarcinoma of Low Malignant Potential Defines Indolent NSCLC Associated With Overdiagnosis in the National Lung Screening Trial.”. Cancer Biomarkers : Section A of Disease Markers 42 (1): CBM230452.